$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000117891314001582 Filed on May 08, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q1
Revenue	$90.00K	$95.00K	$194.0K
YoY Change	-10.0%	-51.03%	-15.65%
Cost Of Revenue	$0.00	$3.000K	$6.000K
YoY Change		-50.0%	0.0%
Gross Profit	$90.00K	$92.00K	$188.0K
YoY Change	0.0%	-51.06%	-16.07%
Gross Profit Margin	100.0%	96.84%	96.91%
Selling, General & Admin	$2.340M	$2.530M	$1.160M
YoY Change	68.35%	118.1%	-39.58%
% of Gross Profit	2600.0%	2750.0%	617.02%
Research & Development		$6.885M	$4.965M
YoY Change		38.67%	45.13%
% of Gross Profit		7483.7%	2640.96%
Depreciation & Amortization	$480.0K	$480.0K	$310.0K
YoY Change	9.09%	54.84%	181.82%
% of Gross Profit	533.33%	521.74%	164.89%
Operating Expenses	$6.810M	$6.885M	$4.965M
YoY Change	-6.84%	38.67%	2.58%
Operating Profit	-$6.720M	-$9.287M	-$5.933M
YoY Change	-6.93%	56.53%	28.7%
Interest Expense	$520.0K	$10.00K	$250.0K
YoY Change	126.09%	-96.0%	-43.18%
% of Operating Profit
Other Income/Expense, Net		$11.00K	$253.0K
YoY Change		-95.65%
Pretax Income	-$6.200M	-$9.280M	-$5.680M
YoY Change	-11.3%	63.38%	36.21%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$6.200M	-$9.276M	-$5.680M
YoY Change	-11.3%	63.31%	36.08%
Net Earnings / Revenue	-6888.89%	-9764.21%	-2927.84%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.91	-$1.41	-$0.97
COMMON SHARES
Basic Shares Outstanding	67.91M shares	64.66M shares	58.33M
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.91M	$60.12M	$59.83M
YoY Change	0.02%	0.48%	51.32%
Cash & Equivalents	$4.493M	$3.638M	$27.82M
Short-Term Investments	$49.41M	$56.48M	$32.01M
Other Short-Term Assets	$905.0K	$876.0K
YoY Change	51.09%
Inventory
Prepaid Expenses	$382.0K
Receivables	$2.263M
Other Receivables	$17.00K
Total Short-Term Assets	$61.99M	$64.71M	$61.11M
YoY Change	12.53%	5.89%	47.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.82M	$11.13M	$11.50M
YoY Change	-8.79%	-3.27%	275.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$300.0K	$320.0K	$790.0K
YoY Change	-28.57%	-59.49%	12.86%
Other Assets	$8.000K	$18.00K	$113.0K
YoY Change	-79.49%	-84.07%	-90.22%
Total Long-Term Assets	$12.04M	$12.68M	$13.23M
YoY Change	-9.03%	-4.14%	143.1%
TOTAL ASSETS
Total Short-Term Assets	$61.99M	$64.71M	$61.11M
Total Long-Term Assets	$12.04M	$12.68M	$13.23M
Total Assets	$74.02M	$77.39M	$74.34M
YoY Change	8.35%	4.1%	58.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.465M	$2.696M	$2.577M
YoY Change	22.14%	4.62%	68.54%
Accrued Expenses	$915.0K	$1.155M	$780.0K
YoY Change	-12.02%	48.08%	239.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.397M	$6.442M	$5.765M
YoY Change	24.93%	11.74%	18.77%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$588.0K	$611.0K	$709.0K
YoY Change	-13.53%	-13.82%	-82.87%
Total Long-Term Liabilities	$4.503M	$4.988M	$4.553M
YoY Change	-8.64%	9.55%	9.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.397M	$6.442M	$5.765M
Total Long-Term Liabilities	$4.503M	$4.988M	$4.553M
Total Liabilities	$11.90M	$11.43M	$10.32M
YoY Change	9.68%	10.78%	14.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$113.8M	-$107.6M	-$79.91M
YoY Change	30.99%	34.7%	29.7%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$62.12M	$65.96M	$64.02M
YoY Change
Total Liabilities & Shareholders Equity	$74.02M	$77.39M	$74.34M
YoY Change	8.35%	4.1%	58.51%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	-$6.200M	-$9.276M	-$5.680M
YoY Change	-11.3%	63.31%	36.08%
Depreciation, Depletion And Amortization	$480.0K	$480.0K	$310.0K
YoY Change	9.09%	54.84%	181.82%
Cash From Operating Activities	-$5.350M	-$5.660M	-$4.980M
YoY Change	6.57%	13.65%	97.62%
INVESTING ACTIVITIES
Capital Expenditures	$130.0K	$270.0K	-$90.00K
YoY Change	-87.74%	-400.0%	-129.03%
Acquisitions
YoY Change
Other Investing Activities	$5.750M	-$5.910M	$9.150M
YoY Change	-143.96%	-164.59%	17.61%
Cash From Investing Activities	$5.600M	-$6.170M	$9.240M
YoY Change	-139.6%	-166.77%	24.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	600.0K	10.84M	30.00K
YoY Change	81.82%	36033.33%
NET CHANGE
Cash From Operating Activities	-5.350M	-5.660M	-4.980M
Cash From Investing Activities	5.600M	-6.170M	9.240M
Cash From Financing Activities	600.0K	10.84M	30.00K
Net Change In Cash	850.0K	-990.0K	4.290M
YoY Change	-104.51%	-123.08%	-12.98%
FREE CASH FLOW
Cash From Operating Activities	-$5.350M	-$5.660M	-$4.980M
Capital Expenditures	$130.0K	$270.0K	-$90.00K
Free Cash Flow	-$5.480M	-$5.930M	-$4.890M
YoY Change	-9.87%	21.27%	72.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001158780
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	67910810	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	PLURISTEM THERAPEUTICS INC
CY2014Q1	psti	Aggregate Grants Received AggregateGrantsReceived	14156000	USD
	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	267000	USD
	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	169000	USD
CY2014Q1	psti	Available For Sale Marketable Securities Number AvailableForSaleMarketableSecuritiesNumber	1011504	shares
CY2013Q2	psti	Available For Sale Securities Gross Unrealized Gain Accumulated In Aoci AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInAoci	570000	USD
CY2014Q1	psti	Available For Sale Securities Gross Unrealized Gain Accumulated In Aoci AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInAoci	2923000	USD
CY2013Q2	psti	Available For Sale Securities Gross Unrealized Loss Accumulated In Aoci AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInAoci	311000	USD
CY2014Q1	psti	Available For Sale Securities Gross Unrealized Loss Accumulated In Aoci AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInAoci	42000	USD
CY2014Q1	psti	Common Stock Aggregate Offering Price Authorized CommonStockAggregateOfferingPriceAuthorized	95000000	USD
	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	3411000	USD
CY2014Q1	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	37000	USD
	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1546000	USD
CY2013Q1	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	3000	USD
	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	-27000	USD
	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	-158000	USD
	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	15078000	USD
CY2014Q1	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	6848000	USD
	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	11313000	USD
CY2013Q1	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	4962000	USD
	psti	Research And Development Milestone Revenue Receivable ResearchAndDevelopmentMilestoneRevenueReceivable	37500000	USD
CY2014Q1	psti	Royalties Amount Paid And Accrued RoyaltiesAmountPaidAndAccrued	50000	USD
	psti	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1	pure
	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Exercised SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised	16500	shares
	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Granted SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted	3000	shares
CY2013Q2	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	315500	shares
CY2014Q1	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	302000	shares
CY2014Q1	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Exercisable SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable	300000	shares
CY2014Q1	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Vested And Expected To Vest SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest	302000	shares
	psti	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	12000	USD
	psti	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	169000	USD
	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	1859000	USD
	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	1679000	USD
CY2014Q1	psti	Warrants And Options Aggregate Intrinsic Value WarrantsAndOptionsAggregateIntrinsicValue	535000	USD
CY2014Q1	psti	Warrants And Options Aggregate Intrinsic Value Exercisable WarrantsAndOptionsAggregateIntrinsicValueExercisable	528000	USD
CY2014Q1	psti	Warrants And Options Aggregate Intrinsic Value Vested And Expected To Vest WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest	535000	USD
	psti	Warrants And Options Exercised Weighted Average Exercise Price WarrantsAndOptionsExercisedWeightedAverageExercisePrice	1.74
	psti	Warrants And Options Granted Weighted Average Exercise Price WarrantsAndOptionsGrantedWeightedAverageExercisePrice	0.00
CY2013Q2	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	4.40
CY2014Q1	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	4.54
CY2014Q1	psti	Warrants And Options Weighted Average Exercise Price Excercisable WarrantsAndOptionsWeightedAverageExercisePriceExcercisable	4.54
CY2014Q1	psti	Warrants And Options Weighted Average Exercise Price Vested And Expected To Vest WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest	4.54
	psti	Warrants And Options Weighted Average Remaining Contractual Term WarrantsAndOptionsWeightedAverageRemainingContractualTerm	P3Y6M7D
	psti	Warrants And Options Weighted Average Remaining Contractual Term Exercisable WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable	P3Y5M12D
	psti	Warrants And Options Weighted Average Remaining Contractual Term Vested And Expected To Vest WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest	P3Y6M7D
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2837000	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2696000	USD
CY2013Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1272000	USD
CY2014Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1951000	USD
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1040000	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1155000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	259000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2875000	USD
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	144109000	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	170721000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1400000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	184000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2694000	USD
CY2013Q2	us-gaap	Assets Assets	68316000	USD
CY2014Q1	us-gaap	Assets Assets	77388000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	55085000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	64709000	USD
CY2013Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	13231000	USD
CY2014Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	12679000	USD
CY2013Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	13441000	USD
CY2014Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	30349000	USD
CY2013Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	13182000	USD
CY2014Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	27468000	USD
	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses	6000	USD
CY2013	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses	9000	USD
	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses	36000	USD
CY2013	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses	302000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	5122000	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1619000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	32000	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	130000	USD
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67849535	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59196617	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67849535	shares
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	146000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1738000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9007000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9389000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3638000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27821000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5369000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	18432000	USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59196617	shares
CY2013Q2	us-gaap	Common Stock Value CommonStockValue		USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue		USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18120000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7560000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13460000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5469000	USD
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	2244574	shares
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1350907	shares
	us-gaap	Cost Of Revenue CostOfRevenue	9000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	3000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	18000	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	6000	USD
CY2013Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	393000	USD
CY2014Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	261000	USD
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2013Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3226000	USD
CY2014Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2941000	USD
CY2013Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	905000	USD
CY2014Q1	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	1220000	USD
	us-gaap	Depreciation Depreciation	1416000	USD
	us-gaap	Depreciation Depreciation	592000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-86000	USD
CY2014Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-29000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	317000	USD
CY2013Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-25000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.33
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2013Q2	us-gaap	Foreign Currency Derivatives At Fair Value Net ForeignCurrencyDerivativesAtFairValueNet	93000	USD
CY2014Q1	us-gaap	Foreign Currency Derivatives At Fair Value Net ForeignCurrencyDerivativesAtFairValueNet	-287000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-35000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6335000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2531000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4260000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1159000	USD
	us-gaap	Gross Profit GrossProfit	276000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	92000	USD
	us-gaap	Gross Profit GrossProfit	566000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	188000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	43000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	15000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	585000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	209000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-132000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-1009000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-285000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-584000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	726000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1612000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-57000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	515000	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	98000	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	19000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	55000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	448000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-117000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-12000	USD
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	3292000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	159000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	278000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68316000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77388000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5921000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6442000	USD
CY2013Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4929000	USD
CY2014Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4988000	USD
CY2011Q3	us-gaap	Licenses Revenue LicensesRevenue	7000000	USD
CY2013Q2	us-gaap	Long Term Investments LongTermInvestments	421000	USD
CY2014Q1	us-gaap	Long Term Investments LongTermInvestments	316000	USD
CY2013Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	13441000	USD
CY2014Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	30349000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-108000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-21000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	12020000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	35967000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3624000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-5661000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13765000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-11874000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20736000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-9276000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14165000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-5680000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	10414000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1		USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	401000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	842000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	253000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21137000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9287000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15007000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5933000	USD
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	872000	USD
CY2014Q1	us-gaap	Other Assets Current OtherAssetsCurrent	876000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	39000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2616000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1716000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	705000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	211000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-108000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-272000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-21000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	2000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-6000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-42000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax		USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax		USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2514000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1486000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	684000	USD
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	680000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	213000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	611000	USD
	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	3000	USD
	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-489000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-1945000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	1408000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	8809000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2537000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1436000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3247000	USD
CY2013Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1023000	USD
CY2014Q1	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	1436000	USD
CY2011Q3	us-gaap	Proceeds From Customers ProceedsFromCustomers	2000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10149000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	34106000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1871000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1861000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	687000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	351000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3875000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	679000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11866000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11125000	USD
	us-gaap	Reimbursement Revenue ReimbursementRevenue	10000000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18489000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6885000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12859000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4965000	USD
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	316000	USD
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3716000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-86902000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-107638000	USD
CY2011Q3	us-gaap	Revenue From Grants RevenueFromGrants	5000000	USD
	us-gaap	Revenues Revenues	285000	USD
CY2014Q1	us-gaap	Revenues Revenues	95000	USD
	us-gaap	Revenues Revenues	584000	USD
CY2013Q1	us-gaap	Revenues Revenues	194000	USD
CY2014Q1	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	14106000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4019000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2105000	USD
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1461000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1862099	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M13D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	11.59
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	81057	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1461000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1958156	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1862099	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.01
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M13D
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1461000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y4M13D
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1862099	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.73
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.83
CY2013Q2	us-gaap	Short Term Investments ShortTermInvestments	31449000	USD
CY2014Q1	us-gaap	Short Term Investments ShortTermInvestments	26130000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	57466000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	37742000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	65958000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	64019000	USD
	us-gaap	Stock Issued1 StockIssued1		USD
	us-gaap	Stock Issued1 StockIssued1	1400000	USD
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2433786	shares
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	1359204	shares
	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2500000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	15000	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10149000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	34106000	USD
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	10414000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4178000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2383000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Use of estimates</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt">  </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <!--EndFragment--></div> </div>
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62098498	shares
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	65607976	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54507538	shares
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58358476	shares

Files In Submission

Name	View Source	Status
0001178913-14-001582-index-headers.html	Edgar Link	pending
0001178913-14-001582-index.html	Edgar Link	pending
0001178913-14-001582.txt	Edgar Link	pending
0001178913-14-001582-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
psti-20140331.xml	Edgar Link	completed
psti-20140331.xsd	Edgar Link	pending
psti-20140331_cal.xml	Edgar Link	unprocessable
psti-20140331_def.xml	Edgar Link	unprocessable
psti-20140331_lab.xml	Edgar Link	unprocessable
psti-20140331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1414868.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2014 Q2 Form 10-Q Financial Statement

#000117891314001582 Filed on May 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2014 Q2 Form 10-Q Financial Statement

#000117891314001582 Filed on May 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur